HIGH DOSE METHOTREXATE (HD-MTX) IN TREATMENT OF EXTRA-RENAL RHABDOID TUMOR (ERRT) WITH DIFFUSE LEPTOMENINGEAL SPREAD

被引：0
|
作者：
Saeed, Haleema [1 ]
Hord, Jeffrey [1 ]
机构：
[1] Akron Childrens Hosp, Akron, OH USA
来源：
PEDIATRIC BLOOD & CANCER | 2013年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [41] Rescue with recombinant Carboxypeptidase G2 (CPG2) in high-dose methotrexate (HD-MTX) induced renal failure:: Results in 42 patients from a German emergency protocol.
    Schwarz, S
    Borner, K
    Müller, K
    Fischer, L
    Korfel, A
    Atkinson, T
    Melton, R
    Thiel, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 745S - 745S
  • [42] Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 83 Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India
    Bajpai, J.
    Talreja, V.
    Karpe, A.
    Vora, T.
    Rekhi, B.
    Gupta, S.
    Banavali, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S121 - S121
  • [43] RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES
    Ferreri, Andres J. M.
    Reni, Michele
    Foppoli, Marco
    Martelli, Maurizio
    Siakantaris, Marina
    Frezzato, Maurizio
    Cabras, Maria Giuseppina
    Fabbri, Alberto
    Corazzelli, Gaetano
    Ilariucci, Fiorella
    Rossi, Giuseppe
    Soffietti, Riccardo
    Stelitano, Caterina
    Vallisa, Daniele
    Zaja, Francesco
    Gelemur, Marta
    Aondio, Gian Marco
    Avvisati, Giuseppe
    Balzarotti, Monica
    Brandes, Alba
    Costa, Maria Joao
    Gomez, Henry
    Guarini, Attilio
    Pinotti, Graziella
    Rigacci, Luigi
    Uhlmann, Catrina
    Ponzoni, Maurilio
    Zucca, Emanuele
    Caligaris-Cappio, Federico
    Cavalli, Franco
    ANNALS OF ONCOLOGY, 2009, 20
  • [44] Randomized phase II trial on primary chemotherapy with high-dose methotrexate (HD-MTX) alone or associated with high-dose cytarabine (HD-araC) for patients with primary CNS lymphoma (IELSG #20 Trial): Tolerability, activity, and survival analyses
    Ferreri, A. J.
    Reni, M.
    Martelli, M.
    Pangalis, G.
    Frezzato, M.
    Cabras, G.
    Fabbri, A.
    Corazzelli, G.
    Zucca, E.
    Cavalli, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [45] HIGH-DOSE METHOTREXATE WITH CITROVORUM FACTOR RESCUE (HD-MTX) ALTERNATING WITH COMBINATION CHEMOTHERAPY (M-CAV-CME) IN SMALL CELL LUNG-CANCER (SC LUNG CA)
    SKARIN, AT
    GREENE, H
    CANELLOS, GP
    TAKVORIAN, R
    FREI, E
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 328 - 328
  • [46] Non- High Dose -Methotrexate (HD-MTX) Based, Dose-Dense (DD), Combination, Chemotherapy(CT) in 243 Non-Metastatic Osteosarcoma Patients: A Tertiary Care Centre Experience from India
    Bajpai, J.
    Talreja, V.
    Karpe, A.
    Rekhi, B.
    Vora, T.
    Banavali, S.
    Gupta, S.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S67 - S67
  • [47] A RANDOMIZED TRIAL OF HIGH-DOSE (HD) VS LOW-DOSE (LD) METHOTREXATE (MTX) IN THE TREATMENT OF EXTENSIVE STAGE SMALL CELL LUNG-CANCER
    HANDE, KR
    OLDHAM, RK
    FER, MF
    RICHARDSON, RL
    GRECO, FA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 505 - 505
  • [48] Comparison of high-dose methotrexate (HD-MTX) with Capizzi methotrexate plus asparaginase (C-MTX/ASNase) in children and young adults with high-risk acute lymphoblastic leukemia (HR-ALL): A report from the Children's Oncology Group Study AALL0232
    Larsen, E. C.
    Salzer, W. L.
    Devidas, M.
    Nachman, J. B.
    Raetz, E. A.
    Loh, M. L.
    Heerema, N. A.
    Carroll, A. J.
    Gastier-Foster, J. M.
    Borowitz, M. J.
    Wood, B. L.
    Willman, C. L.
    Winick, N. J.
    Hunger, S.
    Carroll, W. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (18)
  • [49] Final results of a multicentre phase II trial of high-dose methotrexate (HD-MTX), cytarabine, thiotepa, and idarubicin (MATILDE regimen) followed by whole-brain irradiation (WBRT) for primary CNS lymphomas (PCNSL)
    Ferreri, AJ
    Dell'oro, S
    Foppoli, M
    Brandes, AA
    Montanari, M
    Balzarotti, M
    Spina, M
    Ilariucci, F
    Zaja, F
    Reni, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 121S - 121S
  • [50] ETHNIC-SPECIFIC PREDICTORS OF NEUROTOXICITY AMONG PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS FOLLOWING HIGH-DOSE METHOTREXATE (HD-MTX): A REDUCING ETHNIC DISPARITIES IN ACUTE LEUKEMIA (REDIAL) CONSORTIUM REPORT
    Harris, Rachel
    Zobeck, Mark
    Bernhardt, Melanie
    Rabin, Karen
    Schafer, Eric
    Hsiao, Heidi
    Taylor, Olga
    Lupo, Philip
    Scheurer, Michael
    Brown, Austin
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S353 - S353
12345